temoporfin has been researched along with Mouth Neoplasms in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 5 (33.33) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Visscher, SA; Dijkstra, PU; Hopper, C; Karakullukcu, B; Melchers, LJ; Roodenburg, JL; Tan, IB; Witjes, MJ | 1 |
| Amelink, A; de Bruijn, HS; de Visscher, SA; Robinson, DJ; Roodenburg, JL; Sterenborg, HJ; van der Ploeg-van den Heuvel, A; van der Vegt, B; Witjes, MJ | 1 |
| Bing Tan, I; Copper, MP; Karakullukcu, B; Klop, WM; van Oudenaarde, K; van Veen, R; Wildeman, M | 1 |
| Akram, S; Hamdoon, Z; Hopper, C; Jerjes, W; Mosse, CA; Upile, T | 1 |
| Céruse, P; Cosmidis, A; Durbec, M; Fuchsmann, C; Ramade, A | 1 |
| Ballini, JP; Blant, SA; Glanzmann, TM; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
| Copper, MP; Oppelaar, H; Ruevekamp, MC; Stewart, FA; Tan, IB | 1 |
| Banerjee, AS; Benjamin, E; Dilkes, MG; Ovaisi, S | 1 |
| Hopper, C; Kübler, A; Lewis, H; Putnam, G; Tan, IB | 1 |
| El-Maaytah, M; Hopper, C; Jerjes, W; Khalil, HS; Lewis, MP; Macrobert, AJ; Salih, V; Sharwani, A; Upile, T | 1 |
| Braichotte, D; Folli, S; Glanzmann, T; Monnier, P; Savary, JF; Van den Bergh, H; Wagnieres, G; Westermann, P | 1 |
| Blant, SA; Fontolliet, C; Monnier, P; van den Bergh, H; Wagnières, G; Woodtli, A | 1 |
| Braichotte, D; Fontolliet, C; Mizeret, J; Monnier, P; Savary, JF; van den Bergh, H; Wagnières, G | 1 |
| Bown, SG; Buonaccorsi, GA; Fan, KF; Hopper, C; Speight, PM | 1 |
| Andrejevic-Blant, S; Ballini, JP; Fontolliet, C; Hadjur, C; Monnier, P; van den Bergh, H; Wagnières, G | 1 |
5 trial(s) available for temoporfin and Mouth Neoplasms
| Article | Year |
|---|---|
mTHPC-mediated photodynamic therapy of early stage oral squamous cell carcinoma: a comparison to surgical treatment.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasm Staging; Oral Surgical Procedures; Photochemotherapy; Photosensitizing Agents; Prognosis; Retrospective Studies; Survival Rate | 2013 |
Photodynamic therapy outcome for oral dysplasia.
Topics: Aged; Aminolevulinic Acid; Carcinoma in Situ; Drug Administration Schedule; Female; Humans; Lasers, Semiconductor; Leukoplakia, Oral; Low-Level Light Therapy; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2011 |
Meta-tetra(hydroxyphenyl)chlorin photodynamic therapy in early-stage squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Female; Humans; Lymphatic Metastasis; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Pharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Prospective Studies | 2003 |
mTHPC-mediated photodynamic therapy for early oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Squamous Cell; Female; Health Status; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Pain; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Survival Analysis; Treatment Outcome | 2004 |
Clinical pharmacokinetic studies of tetra(meta-hydroxyphenyl)chlorin in squamous cell carcinoma by fluorescence spectroscopy at 2 wavelengths.
Topics: Aged; Animals; Carcinoma, Squamous Cell; Humans; Male; Mesoporphyrins; Mice; Mice, Nude; Middle Aged; Mouth Neoplasms; Neoplasm Transplantation; Neoplasms, Experimental; Radiation-Sensitizing Agents; Spectrometry, Fluorescence | 1995 |
10 other study(ies) available for temoporfin and Mouth Neoplasms
| Article | Year |
|---|---|
Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
Topics: 4-Nitroquinoline-1-oxide; Animals; Carcinogens; Carcinoma, Squamous Cell; Liposomes; Male; Mesoporphyrins; Microscopy, Confocal; Microscopy, Fluorescence; Mouth Mucosa; Mouth Neoplasms; Observer Variation; Photochemotherapy; Photosensitizing Agents; Rats; Rats, Wistar | 2013 |
Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Disease-Free Survival; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neck Dissection; Oropharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Survival Rate | 2011 |
Efficacy and safety of photodynamic therapy with temoporfin in curative treatment of recurrent carcinoma of the oral cavity and oropharynx.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Hematoporphyrin Photoradiation; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Treatment Outcome | 2013 |
Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.
Topics: Animals; Carbon Isotopes; Carcinoma, Squamous Cell; Cricetinae; Drug Screening Assays, Antitumor; Female; Humans; Light; Mesocricetus; Mesoporphyrins; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents; Species Specificity; Spectrometry, Fluorescence; Tissue Distribution | 2002 |
Treatment of primary mucosal head and neck squamous cell carcinoma using photodynamic therapy: results after 25 treated cases.
Topics: Carcinoma, Squamous Cell; Combined Modality Therapy; Follow-Up Studies; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Mesoporphyrins; Mouth Neoplasms; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Treatment Outcome | 2003 |
Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Tumor; Cells, Cultured; Down-Regulation; Humans; Keratinocytes; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mesoporphyrins; Mouth Neoplasms; Neoplasm Invasiveness; Photochemotherapy; Urokinase-Type Plasminogen Activator; Vascular Endothelial Growth Factor A | 2006 |
In vivo fluence rate effect in photodynamic therapy of early cancers with tetra(m-hydroxyphenyl)chlorin.
Topics: Animals; Carcinoma, Squamous Cell; Cricetinae; Mesocricetus; Mesoporphyrins; Mouth Neoplasms; Neoplasms, Experimental; Photochemotherapy; Radiation-Sensitizing Agents | 1996 |
Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
Topics: Antineoplastic Agents; Biopsy; Bronchial Neoplasms; Carcinoma, Squamous Cell; Esophageal Neoplasms; Evaluation Studies as Topic; Female; Humans; Male; Mesoporphyrins; Microscopy, Fluorescence; Middle Aged; Mouth Neoplasms; Neoplasms, Second Primary; Photochemotherapy; Radiation-Sensitizing Agents | 1997 |
Photodynamic therapy using mTHPC for malignant disease in the oral cavity.
Topics: Adult; Aged; Aged, 80 and over; Female; Humans; Male; Mesoporphyrins; Middle Aged; Mouth Neoplasms; Photochemotherapy; Photosensitizing Agents | 1997 |
Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cheek; Cricetinae; Drug Administration Schedule; Light; Mesocricetus; Mesoporphyrins; Microscopy, Fluorescence; Mouth Neoplasms; Photochemotherapy; Radiation-Sensitizing Agents; Tissue Distribution | 1997 |